Search clinical trials for: oral contraceptive pill (OCP; OCPs)
Total 0 results
Nothing found
Sponsors and Collaborators
- the people hospital of Linzhi
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- National Institute of Cardiovascular Diseases, Bangladesh
- Etan Orgel
- Hospitales Universitarios Virgen del Rocío
- ECMC
- AlpinARC
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Sahachat Aueyingsak
- Daniela Pacella - University of Naples Federico II, Naples
- Centro Universitário Franciscano
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- Glasgow Western Infirmary
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- Dr Philippe METELLUS
- Åke Wibergs Stiftelse
- Sublimity Therapeutics Holdco Limited
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Bassam Abdulkarim
- View Full List
Medical Conditions
- Eosinophil Blood Count
- Panniculectomy
- Orthopaedic Disorders
- Interviews
- Ability to Swim 100m Independent Freestyle
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Genetic Risk Factor
- Legal History
- Patients With Leptomeningeal Disease
- Value-Based Health Insurance
- Transitional Cell Carcinoma of Renal Pelvis
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Initiation of Depo-Provera (DMPA)
- Hyperprolinemia
- Pancreaticoduodenectomy
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Progression to PD-1 Antibody
- Degenerative Spondylolisthesis G1
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- View Full List
Drug Interventions
- Metoclopramide + dexamethasone
- ASP8062
- 5-Fluoro-uracil
- Cefuroxime 750mg oral
- Antibiotic treatment
- 6% hetastarch
- Prasugrel
- Injectable Insulin
- 0% N2O
- HBM4003 and Triprilimab
- Epirubicin hydrochloride
- Omeprazole 20mg
- Nimotuzumab
- Paliperidone palmitate
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- Mepivacaine
- Gefitinib
- UFUR and Iressa
- IV rtPA (intravenous recombinant plasminogen activator)
- Erythropoietin
- View Full List
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Denmark
- Contract Research Organizations in France
- Contract Research Organizations in Germany
- Contract Research Organizations in Guinea
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Poland
- Contract Research Organizations in Zimbabwe
- CRO list by country